title: Targeting the tumor niche to treat cancer.
authors.affiliation: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030;
authors.forename: Sattva S
authors.initials: SS
authors.lastname: Neelapu
authors.affiliation: Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 padsharma@mdanderson.org.
authors.forename: Padmanee
authors.initials: P
authors.lastname: Sharma
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D053645:Interleukin-2 Receptor alpha Subunit / Q000276:immunology*; D008297:Male; D015021:Yttrium Radioisotopes / Q000737:chemistry*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D053645:Interleukin-2 Receptor alpha Subunit; D015021:Yttrium Radioisotopes